Editorial: Recent Advances in Pheochromocytoma and Paraganglioma: Molecular Pathogenesis, Clinical Impacts, and Therapeutic Perspective

Front Endocrinol (Lausanne). 2021 Aug 23:12:720983. doi: 10.3389/fendo.2021.720983. eCollection 2021.
No abstract available

Keywords: cancer management; cancer therapeutics; neuroendocrine tumors; paraganglioma; pheochromocytoma.

Publication types

  • Editorial
  • Introductory Journal Article

MeSH terms

  • Adrenal Gland Neoplasms* / diagnosis
  • Adrenal Gland Neoplasms* / genetics
  • Adrenal Gland Neoplasms* / therapy
  • Carcinogenesis / metabolism
  • Carcinogenesis / pathology
  • Combined Modality Therapy / methods
  • Combined Modality Therapy / trends
  • Endocrinology / methods
  • Endocrinology / trends*
  • Humans
  • Molecular Targeted Therapy / methods
  • Molecular Targeted Therapy / trends
  • Mutation
  • Pheochromocytoma* / diagnosis
  • Pheochromocytoma* / genetics
  • Pheochromocytoma* / therapy
  • Preoperative Care / methods
  • Preoperative Care / trends
  • Prognosis
  • Receptors, G-Protein-Coupled / genetics
  • Risk Assessment
  • Succinate Dehydrogenase / genetics
  • Tumor Hypoxia / genetics
  • Tumor Hypoxia / physiology

Substances

  • Receptors, G-Protein-Coupled
  • SUCNR1 protein, human
  • Succinate Dehydrogenase